Sherry is the perfect drink to have before dinner, said David Wondrich in Saveur, “or after it, or really anytime at all.” Many drinkers have come to regard this fortified wine made in or near the Spanish city of Jerez as somewhat “arcane”—nice to know about, but not really worth ordering.
Sherry’s complex classification system may be “partly to blame.” All sherries start out as fortified white wine aged in oak. Then they’re divided into three categories: pale, dry sherries called flor, which include finos, manzanillas, and amontillados; darker, richer olorosos; and very sweet dessert sherries called PX—for Pedro Ximenez, the grape variety used in them.
Today sherry is “getting a second look.” Its mellow flavor makes it “deeply pleasurable to drink,” and and its old-school charm can’t be beat. Here are four worth trying:
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
González Byass Tio Pepe Fino ($18)
“The benchmark fino. The very essence of dryness.”
Lustau Solera Reserve Dry Oloroso ‘Don Nuño’ ($28)
A classic from a 112-year-old winery.
Sandeman Character Medium Dry Amontillado ($15)
Briny, acidic, perfectly balanced.
Williams & Humbert Dry Sack 15 Year Sweet Old Oloroso ($25) This “perfect dessert wine” is not in the least bit dry.
-
10 upcoming albums to stream during the winter chillThe Week Recommends As the calendar turns to 2026, check out some new music from your favorite artists
-
Kristi Noem might not be long for TrumplandIN THE SPOTLIGHT The Homeland Security secretary has been one of the most visible and vocal architects of Trump’s anti-immigration efforts, even as her own star risks fading
-
Senate votes down ACA subsidies, GOP alternativeSpeed Read The Senate rejected the extension of Affordable Care Act tax credits, guaranteeing a steep rise in health care costs for millions of Americans
